|
Oct 3
|
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last?
|
|
Sep 26
|
Time to Order Your Free At-Home Covid Tests. Here’s How.
|
|
Sep 26
|
Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?
|
|
Sep 25
|
Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development
|
|
Sep 3
|
FDA Approves Novavax's Updated COVID Vaccine Targeting Currently Circulating Variants
|
|
Sep 3
|
Company News for Sep 3, 2024
|
|
Sep 2
|
Novavax Stock Up 9% on FDA Nod for Updated COVID-19 Vaccine
|
|
Sep 2
|
Novavax wins FDA emergency approval for updated Covid-19 vaccine
|
|
Aug 30
|
FDA approves Novavax's updated COVID-19 vaccine
|
|
Aug 30
|
US clears updated COVID shots from Novavax, adding a 3rd fall vaccine option
|
|
Aug 30
|
Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
|
|
Aug 29
|
New COVID vaccines are here. What to know about the latest shots as summer surge continues
|
|
Jul 29
|
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
|
|
Jul 23
|
Novavax's (NVAX) Shares Surge 211% YTD: Time to Buy the Stock?
|
|
Jun 18
|
Novavax’s South African Phase IIb COVID-19 vaccine trial likely to reveal results within next fortnight, source says
|
|
Jun 17
|
Novavax seeks FDA approval for updated Covid-19 vaccine
|
|
Jun 14
|
Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
|
|
Jun 14
|
Is It Too Late to Buy Novavax Stock?
|
|
Jun 11
|
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
|
|
Jun 11
|
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
|